A new study has unveiled when chronic myeloid leukemia, a type of cancer that affects the blood and bone marrow, arises in ...

Researchers from The University of Osaka identify a molecule that can support specific therapeutic targeting of AML with ...

About 6% of pregnancy-related cancers are Hodgkin lymphoma, and 5% are non-Hodgkin lymphoma. Leukemias in pregnancy are rarer ...

One main goal of anti-cancer therapies is to kill tumor cells without affecting the surrounding normal cells. Therefore, many drugs are designed to target tumor-specific antigens, which are molecules ...

MT-401-OTS (Acute Myeloid Leukemia or Myelodysplastic Syndrome ... pipeline prioritization in January 2024 to strategically focus on MT-601 in patients with lymphoma. This announcement also included ...

The adult T-cell leukemia or lymphoma treatment market size has ... 2024 report/leukemia-therapeutics-global-market-report Acute Myeloid Leukemia Global Market Report 2024 report/acute-myeloid ...

They might also help keep the disease from getting worse. For example, it's possible it can turn into acute myeloid leukemia (AML). One in three people with MDS will get AML, but some treatments ...

Announced Positive Outcome of Interim Analysis for its Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML) with ...

The journey of fighting Acute Myeloid Leukemia (AML) in India encompasses severe physical and emotional challenges for both patients and caregivers. Integrating mental health support into cancer ...

Despite advances in cancer treatment in recent years, five-year survival rates for acute myeloid leukemia (AML) remain low at just 30% on average, according to the National Cancer Institute.